Acura Pharmaceuticals Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Palatine IL United States (1935)
Status: No NME R&D (1935)

Organization Overview

First Clinical Trial
2007
NCT00654069
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

niacin (2 trials)

oxycodone (oxycontin) (3 trials)

Drugs in Phase 2 Trials (2)

acetaminophen (tylenol) (1 trial)

hydrocodone (hycodan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Opioid-Related Disorders (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4